Browse studies

Find your next paid study

1 recruiting study matching your filters

A First in Human, Phase 1, Open-Label Study on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of 4A10 Monotherapy In Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

ALT-101 is a first-in-human Phase 1 clinical trial testing a new antibody drug called 4A10 in patients with relapsed or hard-to-treat acute lymphoblastic leuke…

Lymphoblastic LymphomaAcute Lymphoblastic Leukemia ALL

Estimated

~$10 – $8,750

Allterum Therapeutics, IncNCT07586618